Funds to Support Completion of Clinical Program Through Commercialization of Novel Device Designed to Prevent Amputations in Patients with Chronic Limb-Threatening Ischemia LimFlow SA, a pioneer
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Cardiovascular Systems Inc Fiscal Year 2021 Second Quarter Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker today Jack Nielsen, Vice President, Investor Relations and Corporate Communications. Thank you and please go ahead.
John E. Nielsen
Vice President, Investor Relations & Corporate Communications
Thank you, Chris. Good afternoon and welcome to our fiscal 2021 second quarter conference call. With me today are Scott Ward, CSI Chairman, President, Chief Executive Officer; Rhonda Robb, Chief Operating Officer; Jeff Points, Chief Financial Officer; and Dr. Ryan Egeland, Chief Medical Officer.